EcoDrugPlus

Integrin Subunit Beta 6

Ensembl ID : ENSCMIG00000006275
Gene Symbol: ITGB6
4 Cross references
205 Possible Orthologues:

Integrin Subunit Beta 8

Ensembl ID : ENSCMIG00000018078
Gene Symbol: ITGB8
3 Cross references
207 Possible Orthologues:

Interleukin 1 Receptor Associated Kinase 4

Ensembl ID : ENSCMIG00000011257
Gene Symbol: IRAK4
4 Cross references
202 Possible Orthologues:

Interleukin-8-Like

Ensembl ID : ENSCMIG00000009166
Gene Symbol: LOC103188309
3 Cross references
139 Possible Orthologues:

Isocitrate Dehydrogenase (Nadp(+)) 1

Ensembl ID : ENSCMIG00000013750
Gene Symbol: IDH1
4 Cross references
234 Possible Orthologues:

Kelch Like Ech Associated Protein 1

Ensembl ID : ENSCMIG00000011704
Gene Symbol: KEAP1
4 Cross references
189 Possible Orthologues:

Kinase Insert Domain Receptor

Ensembl ID : ENSCMIG00000012774
Gene Symbol: KDR
4 Cross references
199 Possible Orthologues:

Kinesin Family Member 11

Ensembl ID : ENSCMIG00000018236
Gene Symbol: KIF11
4 Cross references
203 Possible Orthologues:

Kinesin Family Member 5b

Ensembl ID : ENSCMIG00000010044
Gene Symbol: KIF5B
4 Cross references
289 Possible Orthologues:

Leukotriene A4 Hydrolase

Ensembl ID : ENSCMIG00000015039
Gene Symbol: LTA4H
3 Cross references
207 Possible Orthologues:

Leukotriene B4 Receptor

Ensembl ID : ENSCMIG00000000990
Gene Symbol: LTB4R
4 Cross references
386 Possible Orthologues:

Lutropin-Choriogonadotropic Hormone Receptor-Like

Ensembl ID : ENSCMIG00000011410
Gene Symbol: LOC103186140
4 Cross references
201 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).